Financial News · Live Terminal

Page 140 of 819

Celltrion's EU Clinical Trial Nod for Crohn's Disease Drug Lapses

Celltrion's (KRX:068270) said approval for Part 1 of its European Phase 3 clinical trial application for Remsima (CT-P13 SC) in pediatric patients with Crohn's Disease has lapsed, according to a Friday filing with the Korea Exchange.The approval lapsed on June 18 after the South Korean biopharmaceutical company opted not to submit Part 2 of the application, citing changes to its clinical development strategy.Under the European Union Clinical Trials Regulation, approval for Part 1 automatically lapses if Part 2 is not filed within two years.Celltrion said plans and timelines for the study will be determined following consultations with regulators on the trial design.Shares of Celltrion fell over 2% in recent trade.

KRX:068270

Asia14d ago

Continental Unit Leases Office Space in Taipei, Taiwan

Continental (TPE:3703) unit North Shore Environment will lease office space in Taipei, Taiwan, from affiliated company Continental Engineering, according to a Thursday Taiwan Exchange filing.The lease covers an area of 176 ping, with a right-of-use asset value of NT$30.8 million.The lease term runs from July 1, 2026, to Dec. 31, 2031, with monthly rental payments.The office space will be used for business operations, it said.

TPE:3703

Asia14d ago

Market Chatter: Singapore to Launch Two BTO Projects in October

Singapore's Housing and Development Board is slated to launch two build-to-order (BTO) projects in Bayshore housing state in its next sales exercise in October, according to a report by the Straits Times on Thursday.The BTO projects will offer a total of 2,500 flats, alongside another project in Tengah, the report added.Around 1,240 of these flats will be reserved for seniors and singles, the report noted.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

^STI

Asia14d ago

Celltrion's EU Clinical Trial Nod for Ulcerative Colitis Drug Lapses

Celltrion (KRX:068270) said approval for Part 1 of its European Phase 3 clinical trial application for Remsima (CT-P13 SC) in pediatric patients with moderately to severely active ulcerative colitis has lapsed, according to a Friday filing with the Korea Exchange.The approval lapsed on June 18 after the South Korean biopharmaceutical company opted not to submit Part 2 of the application, citing changes to its clinical development strategy.Under the European Union Clinical Trials Regulation, approval for Part 1 automatically lapses if Part 2 is not filed within two years.Celltrion said plans and timelines for the study will be determined following consultations with regulators on the trial design.Shares of Celltrion fell over 2% in recent trade.

KRX:068270

Asia14d ago

Market Chatter: Genting Unveils $20 Billion Smart City Project in Johor-Singapore Economic Zone

Genting (KLSE:GENM, SGX:G13) has launched a SG$20 billion smart city project, which features an AI research facility in Johor, Malaysia, near the Johor-Singapore Special Economic Zone, Nikkei reported Thursday.The development named Johor Tech Smart City, spans across 9.3 square kilometers, and has attracted participation from Huawei Technologies and Chinese humanoid robot developer, Agibot Innovation Technology, the report said.Near the special economic zone, the site provides the Malaysia- and Singapore-listed company with tax incentives, with the developer planning long-stay residential spaces, the report noted.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

KLSE:GENMSGX:G13

Asia14d ago

Southern Cross Electrical Engineering Says Citigroup Becomes Substantial Holder

Southern Cross Electrical Engineering (ASX:SXE) received notice that Citigroup Global Markets Australia and its affiliated entities became a substantial holder of the company on Tuesday, according to a Friday filing with the Australian bourse.Citigroup now owns over 14 million shares in the company, representing a 5.27% total voting power, the filing said.

ASX:SXE

Asia14d ago

Qantas Airways Reaffirms Project Sunrise Earnings Potential, Jarden Says

Qantas Airways (ASX:QAN) reaffirmed its Project Sunrise target of contributing AU$400 million in earnings before interest and taxes at full fleet scale, with premium seating, a Sydney-and-Perth hub strategy, and fleet optimization serving as key elements of the business case, Jarden said in a note on Thursday.Qantas and Airbus revealed that the Airbus A350 that will serve as the backbone of Project Sunrise operations, confirming Sydney to London as the launch route set for October 2027, with ticket sales planned to open in February 2027.Jarden said the Project Sunrise investment case remains broadly unchanged from the airline's 2023 strategy day despite higher fuel costs and strong premium demand, which will remain key investor focus areas ahead of fiscal 2026 results.The investment firm noted that the airline is targeting about a 20% yield premium on Project Sunrise flights versus its current long-haul network, driven mainly by a higher share of premium seats, with the remainder coming from higher fares.The firm emphasized that the airline's Sydney-and-Perth hub strategy could consolidate demand to support ultra-long-haul load factors, while potential New Zealand market share gains could add feeder traffic without materially cannibalizing existing routes.Jarden added that fleet strategy remains a key investor focus, with fiscal 2026 results expected to provide more detail on A380 retirements and how the airline will optimize its A330, A350 and Boeing 787 fleets to support returns while maintaining network coverage.Jarden reaffirmed its buy rating on Qantas Airways and its AU$11.25 price target.Qantas Airways' shares were up nearly 1% in recent Friday trade.

ASX:QAN

Asia14d ago

Cloudbreak Pharma Secures $15 Million from ARC Group

Cloudbreak Pharma (HKG:2592) agreed to sell $15 million worth of shares to ARC Group, an investment bank and management consultancy firm, according to a Thursday filing with the Hong Kong bourse.Cloudbreak will sell up to 167.8 million shares, representing 20% of the company's issued share capital.Proceeds from the share sale will be used to advance the company's drug pipeline and to repay loans. Funds will also be used for working capital, the firm said.

HKG:2592

Asia15d ago

Shandong Hi-Speed's April Power Output Falls 23%

Shandong Hi-Speed New Energy Group (HKG:1250) generated about 470,682 megawatt-hours of power from its projects in April, down 23% from a year prior, a Thursday Hong Kong bourse filing said.Aggregate power generation for the four months ended April 30 fell 16% to 1.77 million megawatt-hours.

HKG:1250

Asia15d ago

Ono Pharmaceutical to Dispose of 47 Million Yen Treasury Shares Under Stock Compensation Plan

Ono Pharmaceutical (TYO:4528) board approved the disposal of 20,900 treasury shares totaling 47 million yen under its tenure-based restricted stock compensation plan.The board has also approved the disposal of 179,000 treasury shares totaling 402.7 million yen under its performance-based restricted stock compensation plan.The tenure-based shares were allocated to three directors, excluding outside directors, while performance-based shares were allocated to three directors, excluding outside directors, and 13 corporate officers, not on the company board, according to a Thursday filing on the Tokyo Stock Exchange.The disposal will be completed on July 10.Ono's shares fell 2% in recent trade.

TYO:4528

Asia15d ago

Singapore Reclaims Top Spot in IMD Global Competitiveness Ranking

Singapore has reclaimed the top spot in IMD business school's annual world competitiveness ranking, surpassing Switzerland, according to a report released on Thursday.The city-state displaced Switzerland from the top, based on its economic performance, business, government efficiency and infrastructure.Switzerland's descent to number three was largely due to weaker economic performance, driven by high U.S. tariffs and lower foreign direct investment in 2025, according to IMD professor, Arturo Bris, as cited by the Reuters in a report on Thursday.

^STI

Asia15d ago

Cholamandalam Investment Raises INR1 Billion Through Allotment of Securities

Cholamandalam Investment and Finance Company (NSE:CHOLAFIN, BOM:511243) has raised 1 billion Indian rupees through the allotment of secured non-convertible securities on a private placement basis, according to a Thursday filing to the Indian stock exchanges.The company allotted 10,000 securities, which carry a coupon rate of 8.08% per annum and are scheduled to mature on June 5, 2029.They are listed in the wholesale debt market segment of the National Stock Exchange of India.

BOM:511243NSE:CHOLAFIN

Asia15d ago

Hyundai Rotem Wins KRW748.3 Billion Morocco ONCF EMU LTSS Project

South Korean defense products and equipment maker Hyundai Rotem (KRX:064350) secured the Morocco ONCF electric multiple units (EMU) logistique, transport de marchandises et services (LTSS) project from the country's national railway operator, the Office National des Chemins de Fer (ONCF).The contract is valued at 748.25 billion won, according to a Friday filing with the Korea Exchange.Under a shareholder agreement between Hyundai Rotem and ONCF, the contract counterparty is expected to be changed to a joint venture that will be established ahead. The contract's expiration date will be finalized once the JV is established.Shares of Hyundai Rotem fell over 1% in recent trade.

KRX:064350

Asia15d ago

Bank of Jiujiang to Issue 3.6 Billion Yuan Worth of Shares

Bank of Jiujiang (HKG:6190) agreed to issue 3.6 billion yuan worth of domestic shares to investors, according to a Thursday filing with the Hong Kong bourse.The firm plans to issue 494.2 million domestic shares at 7.29 yuan each to the Jiujiang Finance Bureau and at least six other subscribers in batches.The Jiujiang Finance Bureau already owns 14.26% of the business.Funds from the share sale will help replenish the bank's core tier-one capital, it said.

HKG:6190

Asia15d ago

Lum Chang to Dispose of Over 12 Million Shares in Lum Chang Creations

Lum Chang (SGX:L19) has proposed to sell up to 12.3 million shares in its unit, Lum Chang Creations (SGX:LCC), for around SG$9.3 million, as part of regulatory requirements for the unit's proposed transfer to the Mainboard of the Singapore Exchange Securities Trading.Under the placement agreement, around 35 million Lum Chang Creations shares will be up for sale at SG$0.759 per share, including 7.7 million shares to be sold by LCC managing director Lim Thiam Hooi and 15 million shares to be placed by LCC, according to a Thursday bourse filing.Following the conclusion of the exercise, Lum Chang's stake in Lum Chang Creations will be 64.15%.Proceeds raised from the share disposal will be utilized for the repayment of bank borrowings and for general working capital.

SGX:L19SGX:LCC

Asia15d ago

Sunshine Lake Pharma Appoints Chairman

Sunshine Lake Pharma (HKG:6887) said Zhang Yingjun was elected as chairman of the company's board, according to a Thursday filing with the Hong Kong bourse.The appointment will be effective until the company's next annual meeting.

HKG:6887

Asia15d ago

Lunnon Metals Reports Nearly 154,000 Bank Cubic Meters Total Volume Mined at Western Australia Mine; Shares Down 3%

Lunnon Metals (ASX:LM8) reported nearly 154,000 bank cubic meters of total volume mined at the Lady Herial open pit gold mine in Western Australia as of the end of May, according to a Friday filing with the Australian bourse.The total ore mined was over 52,000 tonnes at 1.71 grams per tonne grade of gold containing 2,865 gold ounces, the filing said.The ore purchase agreement with Gold Fields subsidiary, St Ives Gold Mining Co., continues to operate as planned, with over 144,000 tonnes at 1.53 g/t grade of gold delivered to date, per the filing.Shares fell 3% in afternoon trade on Friday.

ASX:LM8

Asia15d ago

Hong Kong Authorities Search Greentown China Office

Greentown China (HKG:3900) said Hong Kong authorities searched its local office as part of a corruption investigation into a former director, according to a Thursday filing with the Hong Kong bourse.The firm said it is assisting with the Independent Commission Against Corruption of Hong Kong and that its business operations remain normal in all material aspects.

HKG:3900

Asia15d ago

AML3D Completes Around AU$4.5 Million Industrial Metal 3D Printing Systems Order for HII Division, Shares Up 3%

AML3D (ASX:AL3) completed an initial order of around AU$4.5 million for the first two, custom, large-scale, ARCEMY X industrial metal 3D printing systems for Newport News Shipbuilding, a division of US-based military shipbuilder HII, according to a Friday Australian bourse filing.A second order of around AU$9.9 million from Newport for four additional custom, large-scale, ARCEMY X systems is expected to be delivered in early 2027 from AML3D's US technology and manufacturing hub in Stow, Ohio.Its shares rose 3% in recent trading on Friday.

ASX:AL3

Asia15d ago

Sichuan Expressway Plans 3.18 Billion Yuan Share Offering

Sichuan Expressway (HKG:0107, SHA:601107) plans to sell 3.18 billion yuan worth of shares to investors, according to a Thursday filing with the Hong Kong bourse.The firm plans to issue up to 432.5 million A shares to raise funds for an expansion project on the Jingkun expressway and to repay debt.The share offering is subject to shareholder approval and would result in the sale of 20% of the company's existing issued A share capital.

HKG:0107SHA:601107

Showing 2781-2800 of 16363